Technologies developed for genome editing are repurposed to study functions of chromatin modifications.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Nature Communications Open Access 10 August 2016
Epigenetics & Chromatin Open Access 18 March 2015
Clinical Epigenetics Open Access 04 March 2015
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Maeder, M.L. et al. Nat. Biotechnol. 31, 1127–1132 (2013).
Mendenhall, E.M. et al. Nat. Biotechnol. 31, 1133–1138 (2013).
Konermann, S. et al. Nature 500, 472–476 (2013).
Joung, J.K. & Sander, J.D. Nat. Rev. Mol. Cell Biol. 14, 49–55 (2013).
Gaj, T., Gersbach, C.A. & Barbas, C.F. Trends Biotechnol. 31, 397–405 (2013).
Wiedenheft, B., Sternberg, S.H. & Doudna, J.A. Nature 482, 331–338 (2012).
Jones, P.A. Nat. Rev. Genet. 13, 484–492 (2012).
Williams, K., Christensen, J. & Helin, K. EMBO Rep. 13, 28–35 (2012).
Calo, E. & Wysocka, J. Mol. Cell 49, 825–837 (2013).
Mosammaparast, N. & Shi, Y. Annu. Rev. Biochem. 79, 155–179 (2010).
Kennedy, M.J. et al. Nat. Methods 7, 973–975 (2010).
The authors declare no competing financial interests.
About this article
Cite this article
Voigt, P., Reinberg, D. Epigenome editing. Nat Biotechnol 31, 1097–1099 (2013). https://doi.org/10.1038/nbt.2756
This article is cited by
Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation
Molecular Therapy (2016)
Nature Communications (2016)
Epigenetics & Chromatin (2015)
Clinical Epigenetics (2015)